Executive dysfunction in medication-naïve children with ADHD: A multi-modal fNIRS and EEG study

Yoshimi Kaga1, Riyo Ueda2, Miho Tanaka2

  • 1Department of Developmental Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi-cho, Kodaira, Tokyo 187-8553, Japan; Department of Pediatrics, Faculty of Medicine, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi 409-3898, Japan.

Brain & Development
|June 14, 2020
PubMed
Summary

Children with attention deficit hyperactivity disorder (ADHD) show altered brain activity, specifically reduced oxygenated hemoglobin and delayed brain responses during cognitive tasks. These neurophysiological changes may serve as biomarkers for executive dysfunction in ADHD.